CONTENTS
This document contains two legally binding instruments governing your use of Teledoc services.
TERMS & CONDITIONS
- Acceptance of Terms
- Nature of Services — Telehealth
- Teledoc Weight Loss Programme — Specific Terms
- GLP-1 Therapy — Specific Terms
- Patient Eligibility & Screening
- Programme Fees, Payments & Refunds
- Patient Obligations
- Limitation of Liability
- Medical Disclaimer
- Intellectual Property
- Governing Law & Dispute Resolution
- Amendments
These Terms and Conditions ("Terms") constitute a legally binding agreement between you ("Patient," "User") and Teledoc ("Company," "Platform") governing your access to and use of www.teledoc.world and all associated services, including but not limited to teleconsultation, the Teledoc Metabolic Weight Loss Program (TMWLP), GLP-1 therapy, dietary and lifestyle guidance, nutraceutical recommendations, and WhatsApp-based support. Please read these Terms carefully before enrolling. By accessing the website or enrolling in any programme, you confirm that you have read, understood, and agree to be bound by these Terms.
1.Acceptance of Terms
Your access to Teledoc services constitutes acceptance of these Terms, our Privacy Policy, and any programme-specific agreements. If you do not agree, you must not use our services. These Terms supersede any prior oral or written representations. Teledoc reserves the right to amend these Terms (see Clause 12) ; continued use after notification of changes constitutes acceptance.
2. Nature of Services — Telehealth
Teledoc provides telehealth services in accordance with the Telemedicine Practice Guidelines 2020 issued by the Board of Governors in Supersession of the Medical Council of India (MoHFW), and applicable CDSCO regulations. Teledoc services are provided by registered medical practitioners (“RMPs”) holding valid, current MBBS or equivalent qualifications registered with the Medical Council of India or relevant State Medical Council.
Teledoc services constitute medical consultation and clinical support. However, the following limitations apply to the telemedicine context:
- Teleconsultation does not replace the need for in person physical examination in all circumstances. Your treating physician will advise you when in person evaluation is necessary.
- Prescriptions issued via Teledoc are valid only for conditions amenable to telemedicine management under the 2020 Guidelines. Certain medications and conditions are excluded from remote prescribing.
- Emergency medical conditions require in-person emergency care. Teledoc is not an emergency service. If you experience a medical emergency, contact emergency services immediately (National Emergency Number: 112).
3. Teledoc Weight Loss Programme — Specific Terms
Teledoc Weight Loss is a structured, multi-component, doctor-supervised weight loss programme based on the proprietary Teledoc Metabolonomics Framework — a system that classifies patients by dominant metabolic phenotype to personalise treatment. The programme integrates metabolonomic assessment, dietary modification (vegetarian-focused), resistance training guidance, nutraceutical supplementation, behavioural support, and pharmacotherapy (GLP-1 therapy) where clinically indicated.
Teledoc Weight Loss Programe is offered across four subscription tiers with different levels of monitoring, support, and pharmacotherapy access. Current pricing is published on www.teledoc.world. All plans include access to a registered physician and WhatsApp-based support. The exact scope of each plan is as described at the time of purchase; Teledoc reserves the right to revise plan contents with 30 days’ prior notice to active subscribers.
Teledoc Weight Loss Programe is a minimum 12-week programme. Outcomes depend on individual patient factors including adherence, metabolic phenotype, co-morbidities, and pharmacotherapy response. While Teledoc clinicians apply evidence-based protocols, no specific weight loss outcome or result can be guaranteed. Individual results will vary. Any outcome projections or averages communicated by Teledoc are illustrative only.
4. GLP-1 Therapy — Specific Terms
GLP-1 receptor agonist therapy (semaglutide, tirzepatide, or equivalent) is a prescription-only medicine under Schedule H of the Drugs and Cosmetics Act 1940. It is prescribed only when clinically indicated following assessment by a registered Teledoc physician. Self-medication or procurement of GLP-1 agents without a valid prescription is illegal and dangerous.
- GLP-1 prescriptions are issued solely at the clinical discretion of your treating Teledoc physician. A paid programme subscription does not automatically entitle you to GLP-1 therapy.
- GLP-1 medications are procured by you directly from Teledoc’s pharmacy partners using the valid prescription. Teledoc does not supply, dispense, or hold inventory of any medicines.
- You must disclose all current medications, known allergies, and prior medical history accurately and completely to your treating physician. Withholding information that affects prescribing safety constitutes a material breach of these Terms.
- You must report any adverse effects, side effects, or unexpected symptoms to your Teledoc physician promptly via WhatsApp. Do not discontinue or alter your dose without medical advice.
- GLP-1 therapy is contraindicated in certain conditions (personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia type 2, current pregnancy or breastfeeding, and others). Your treating physician will assess contraindications during consultation.
- Teledoc accepts no liability for adverse events arising from failure to disclose material health information, self-modification of prescribed doses, or procurement of GLP-1 agents outside of Teledoc’s pharmacy partners.
5. Patient Eligibility & Screening
Teledoc Weight Loss Programe is designed for adults aged 18 to 70 years with a BMI ≥25 kg/ m² (or ≥23 kg/m² with co-morbidities such as type 2 diabetes, PCOS, NAFLD, hypertension, or dyslipidaemia). Eligibility is confirmed by your treating physician during the initial consultation. Teledoc reserves the right to decline enrolment or discontinue programme participation if clinical assessment reveals that telehealth-based management is not appropriate for your condition. Patients with the following conditions require additional in-person evaluation before Teledoc Weight Loss Programe enrolment can proceed: active psychiatric illness requiring hospitalisation; current pregnancy; severe renal impairment (eGFR <30); active malignancy; or acute cardiovascular event within the preceding 3 months.
6. Programme Fees, Payments & Refunds
Programme fees are payable in advance at the time of enrolment. All fees are denominated in Indian Rupees (₹) and are inclusive of applicable GST unless otherwise stated. Current fee schedules are published on www.teledoc.world and are subject to change with 15 days’ notice for new enrolments.
Given the personalised clinical nature of TMWLP, the following refund policy applies:
- Pre-consultation cancellation: Full refund if cancellation is made before the initial consultation is conducted.
- Post-initial consultation: A 50% refund is available within 7 days of the initial consultation if the patient has not received a personalised treatment plan.
- After treatment plan delivery: No refund is available once a personalised metabolonomic report and treatment plan have been delivered.
- Clinical discontinuation: If Teledoc’s physician determines that the programme is clinically unsuitable for you (independently of your choice), a proportionate refund will be offered at Teledoc’s discretion.
- Medication costs: Costs of GLP-1 medications and laboratory investigations are separate from programme fees and are subject to the refund policies of the respective pharmacy and laboratory partners.
Refund requests must be submitted in writing to support@inteledoc.com. Processing time is 7–14 business days from approval.
7. Patient Obligations
As a TMWLP participant, you agree to:
- Provide accurate, complete, and up-to-date personal and medical information at all stages of the programme.
- Attend scheduled teleconsultations and respond to follow-up communications within the timeframes requested by your physician.
- Adhere to the prescribed treatment plan including dietary modifications, exercise protocols, medication schedules, and investigation timelines.
- Promptly report any new symptoms, side effects, medical events, or changes in other medications to your treating Teledoc physician.
- Use Teledoc services only for lawful, personal healthcare purposes and not for resale, commercial use, or as a substitute for emergency care.
- Not share your account or programme materials with third parties.
- Seek in-person medical care promptly when advised to do so by a Teledoc physician.
8. Limitation of Liability
To the maximum extent permitted under applicable Indian law:
- Teledoc’s aggregate liability to you for any claim arising out of or related to these Terms or your use of TMWLP shall not exceed the total fees paid by you in the 12 months preceding the event giving rise to the claim.
- Teledoc is not liable for indirect, incidental, consequential, or punitive damages, including loss of earnings, loss of opportunity, or costs of alternative medical treatment.
- Teledoc is not liable for the acts or omissions of third-party pharmacy partners, laboratory partners, or technology providers, except to the extent caused by Teledoc’s own negligence in selecting or instructing such parties.
- Nothing in this Clause limits Teledoc’s liability for death, personal injury, or fraud caused by the gross negligence or wilful misconduct of a Teledoc-registered practitioner.
9. Medical Disclaimer
Information published on www.teledoc.world — including blog posts, condition pages, educational content, diet plans, and programme descriptions — is intended for general informational purposes only. It does not constitute a clinical diagnosis, medical advice, or a patient-doctor relationship. Only personalised advice from a registered Teledoc physician in the context of an active consultation constitutes medical guidance. Always consult a qualified healthcare professional before making decisions about your health, medications, or medical conditions. Content on this website is not a substitute for in-person medical evaluation.
Content on this website regarding metabolonomics, GLP-1 therapy, specific medical conditions (PCOS, fatty liver, psoriatic arthritis, diabetes), and weight loss outcomes is based on published scientific literature and clinical experience. It reflects the practice frameworkof Teledoc’s clinical team and may not represent the consensus of all medical professionals or regulatory bodies.
10. Intellectual Property
All content on www.teledoc.world — including the Teledoc Metabolonomics Framework, Teledoc Weight Loss Programe protocol, programme design, dietary frameworks, website design, text, graphics, branding, and clinical tools — is the intellectual property of Teledoc or its licensors and is protected under the Copyright Act 1957 and other applicable Indian intellectual property laws.
Personalised treatment plans, meal plans, and clinical reports delivered to you as part of TMWLP are licensed to you for your personal use only. You may not reproduce, distribute, or commercially exploit any Teledoc content without prior written permission.
11. Governing Law & Dispute Resolution
These Terms are governed by and construed in accordance with the laws of the Republic of India. Any dispute arising out of or relating to these Terms, Teledoc Weight Loss Programe, or Teledoc services shall be subject to the exclusive jurisdiction of the courts of Gurugram, Haryana, India.
Before initiating legal proceedings, parties agree to attempt goodfaith resolution through negotiation. If unresolved within 30 days, disputes may be referred to mediation under the Mediation Act 2023 before or concurrently with litigation. Consumer disputes may also be referred to the relevant Consumer Disputes Redressal Forum under the Consumer Protection Act 2019.
For complaints about the professional conduct of a registered medical practitioner, patients may contact the relevant State Medical Council or the National Medical Commission.
12. Amendments to These Terms
Teledoc may amend these Terms or the Privacy Policy at any time. Material changes will be notified to active programme participants via WhatsApp and/or email at least 15 days before the changes take effect. The updated Terms will be published on www.teledoc.world with a revised effective date. Continued use of Teledoc services after the effective date constitutes your acceptance of the revised Terms. If you do not accept the revised Terms, you must notify us and discontinue use.
By enrolling in Teledoc Weight Loss Programe or using any Teledoc service, you acknowledge that you have read and understood both the Privacy Policy and these Terms and Conditions, and that you consent to the collection and use of your health data as described herein.
These documents are published in English. In the event of any conflict between an English version and a translated version in any regional language, the English version shall prevail.